Hartree Partners’s Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share FCAX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$15.6K Hold
20,000
﹤0.01% 132
2021
Q3
$17.6K Hold
20,000
﹤0.01% 158
2021
Q2
$21.6K Buy
+20,000
New +$20.1K 0.01% 174

Other funds holding FCAX.WS

Hartree Partners's FCAX.WS Position: Q2 2021 in Review

Hartree Partners sold out of Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (FCAX.WS) in Q2 2021, closing a stake of 20,000 shares — an estimated $20.1K sold.

Hartree Partners first reported a position in FCAX.WS in Q1 2021 and held it in 1 quarter. The position peaked at $19.8K in Q1 2021. 49 funds tracked by Wall St. Rank hold FCAX.WS as of Q2 2021.

  • Hartree Partners reported no remaining Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q2 2021 after selling out during the quarter.
  • Hartree Partners sold 20,000 Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q2 2021, an estimated $20.1K.
  • Hartree Partners first reported a position in Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2021 and held it in 1 quarter.
  • Hartree Partners's Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $19.8K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q2 2021.

Based on Hartree Partners's 13F filing for Q2 2021, filed 17 Aug 2021.